Related Experiment Videos
Myasthenia gravis and Schmidt syndrome
1Department of Medicine, Inverclyde Royal Hospital, Greenock, UK.
Postgraduate Medical Journal
|October 1, 1988
Summary
A woman with generalized myasthenia gravis developed new symptoms, revealing co-existing autoimmune conditions: primary hypothyroidism and primary adrenal failure (Schmidt syndrome). This case highlights the complex interplay of autoimmune disorders.
Area of Science:
- Endocrinology
- Neurology
- Immunology
Background:
- Generalized myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
- Long-term MG management often involves symptomatic treatment like pyridostigmine and ephedrine.
- Autoimmune conditions can present with overlapping or sequential development.
Observation:
- A 47-year-old woman with a 30-year history of stable generalized myasthenia gravis presented with a 2-month history of worsening weakness.
- She also reported nausea, vomiting, and intermittent confusion.
- Investigations revealed primary hypothyroidism and primary adrenal failure, consistent with Schmidt syndrome.
Findings:
- The patient's autoimmune aetiology was confirmed by positive antibodies.
- Specific antibodies detected included acetylcholine receptor (AChR), adrenal, and thyroid microsomal antibodies.
- These findings confirmed the co-occurrence of myasthenia gravis, hypothyroidism, and adrenal insufficiency.
Implications:
- This case underscores the importance of considering concurrent autoimmune endocrinopathies in patients with established autoimmune neurological disorders.
- Early diagnosis and management of Schmidt syndrome are crucial to prevent life-threatening adrenal crises.
- Further research into the shared autoimmune pathways underlying these conditions may offer novel therapeutic targets.